PALISADE CAPITAL MANAGEMENT, LP - ONYX PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
PALISADE CAPITAL MANAGEMENT, LP ownership history of ONYX PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2013$5,712,000
-18.1%
2,500,000
-16.2%
0.16%
-24.1%
Q1 2013$6,976,000
-1.9%
2,983,000
-14.8%
0.22%
-6.5%
Q4 2012$7,109,0003,500,0000.23%
Other shareholders
ONYX PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
TENOR CAPITAL MANAGEMENT Co., L.P. 40,380,000$129,999,00012.29%
GLAZER CAPITAL, LLC 6,785,000$21,895,0006.50%
WHITEBOX ADVISORS LLC 23,848,000$76,525,0004.04%
ANGELO GORDON & CO., L.P. 11,500,000$36,843,0002.38%
Kohlberg Kravis Roberts & Co. L.P. 32,877,000$105,206,0001.99%
Polar Asset Management Partners Inc. 7,500,000$24,061,0001.02%
FARALLON CAPITAL MANAGEMENT LLC 8,035,000$25,801,0000.53%
D. E. Shaw & Co., Inc. 35,580,000$114,163,0000.18%
AQR Capital Management 11,885,000$38,136,0000.13%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 2,104,000$6,741,0000.07%
View complete list of ONYX PHARMACEUTICALS INC shareholders